A Singaporean healthtech leader that has created a tech solution to connect cancer patients, hospitals and industry in real time will establish its Australian headquarters in Melbourne.
Minister for Economic Development Tim Pallas announced today that the opening of the Oncoshot Australian office will create 50 highly skilled jobs, enhancing the state’s clinical and cancer research ecosystem.
Oncoshot’s technology helps oncologists identify cancer clinical trials more efficiently and effectively for patients and their caregivers by supporting hospitals and research partners.
The Australian office will hire workers in research and development, oncology big data, artificial intelligence (AI), software and business development.
Built on data and insights, the company’s focus is to leverage AI technology to address the inefficiencies of cancer clinical trials. The platform will support the deployment of relevant and innovative clinical trials for patients across public and private cancer institutes in Australia when fully deployed.
Top Australian Brokers
Oncoshot has signed its first Australian partner, Omico, which is one of the country’s leading cancer research networks. This partnership will create opportunities for patients in Omico’s network of hospitals across Australia to participate in global clinical trials.
Founded in 2018 by Dr Huren Sivaraj, a medical oncologist, and Ruslan Enikeev, a data science engineer, Oncoshot’s data system was designed to analyse large amounts of data across healthcare institutions and regional and national borders while observing data protection regulations.
This investment demonstrates the effectiveness of the Andrews Labor Government’s International Investment Strategy in attracting global companies from growth industries to create jobs and boost innovation.
Victoria is the nation’s leading hub for health and medical research, consistently receiving more than 40 per cent of Commonwealth Government funding from the National Health and Medical Research Council (NHMRC). The sector supports more than 30,000 jobs across institutes, universities and industry.